Greenwich LifeSciences GLSI
Greenwich LifeSciences, Inc. · Nasdaq · Pharmaceutical Preparations
$18.31+5.11%close on Oct. 28, 2026 · volume 127K · Yahoo Finance
Price, last 47 sessions
Our coverage
Nothing published yet.
Insider buying and selling
| Date | Insider | Trade | Shares | Avg. price | Value |
|---|---|---|---|---|---|
| July 29, 2026 | Snehal Patel CEO and CFO, director, 10% owner | Bought | 700 | $13.10 | $9,170 |
| July 28, 2026 | Snehal Patel CEO and CFO, director, 10% owner | Bought | 1,500 | $13.59 | $20,385 |
| July 27, 2026 | Snehal Patel CEO and CFO, director, 10% owner | Bought | 1,500 | $13.62 | $20,430 |
| July 24, 2026 | Snehal Patel CEO and CFO, director, 10% owner | Bought | 1,100 | $12.88 | $14,168 |
| July 23, 2026 | Snehal Patel CEO and CFO, director, 10% owner | Bought | 2,500 | $13.14 | $32,850 |
Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.